Nuvectis Pharma (NVCT) stock falls as company posts interim data from a Phase 1b trial for its ovarian cancer drug candidate
https://seekingalpha.com/news/4290861-nuvectis-stock-sinks-data-cancer-drug
Nuvectis Pharma (NVCT) stock falls as company posts interim data from a Phase 1b trial for its ovarian cancer drug candidate
https://seekingalpha.com/news/4290861-nuvectis-stock-sinks-data-cancer-drug
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.